Literature DB >> 31922326

Therapeutic plasma exchange in pediatric intensive care: Indications, results and complications.

Guntulu Sık1, Asuman Demirbuga1, Agageldi Annayev1, Arzu Akcay2, Agop Çıtak1, Gülyüz Öztürk2.   

Abstract

Therapeutic plasma exchange (TPE) is an effective treatment method in selective indications. Secondary to access and technical features, it is more difficult to apply in pediatric population than adults. The aim of this study is investigate safety, clinical indications, and results of this method in critically ill pediatric patients who need TPE treatment. All of the TPE procedures performed in a pediatric intensive care unit providing tertiary care during 4 years (2015-2019) were evaluated retrospectively. TPE procedures (635) were performed for 135 patients. Median age was 34 months (10-108). Ninety-seven patients had mechanical ventilation support. Sepsis with multiple organ failure was the most frequent indication and accounted for 44.4% (n = 60) of the indications followed by hematological and neurological diseases (19.2% and 9.6% respectively). TPE was performed alone in 469 cases (73.9%), in combination with continuous renal replacement therapy in 154 cases (24.2%), and additional to extracorporeal membrane oxygenation in 12 cases (1.9%). Hematological disease and sepsis subgroups had the highest intubation rate, mechanical ventilation period, PRISM score, organ failure count, and mortality. Fresh frozen plasma (FFP) was the most frequently used replacement fluid in 90.4% of the procedures. The most frequent anticoagulant used in TPE was acid citrate dextrose solution (79.3%). Procedural complications were detected in 104 cases (16.3%) and occurred during TPE sessions. Overall survival rate was 78.5%. We found that the non-survivor group had significantly higher rates of organ failures (P = 0.0001), higher PRISM scores on admission (P = 0.0001), and higher rates of invasive ventilation support needed (P = 0.012). TPE is a treatment method which can be safely provided in healthcare facilities with necessary medical and technical requirements. Although it is riskier to provide such treatment to critically ill children, complications can be minimized in experienced healthcare facilities. Overall results are good and can vary depending on indication.
© 2020 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Keywords:  acute disseminated encephalomyelitis; multiorgan dysfunction syndrome; pediatric intensive care; sepsis; therapeutic plasma exchange; thrombotic microangiopathy

Mesh:

Year:  2020        PMID: 31922326     DOI: 10.1111/1744-9987.13474

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  5 in total

1.  Role of therapeutic apheresis in the treatment of pediatric kidney diseases.

Authors:  Shweta Shah; Catherine Joseph; Poyyapakkam Srivaths
Journal:  Pediatr Nephrol       Date:  2021-05-15       Impact factor: 3.714

2.  Therapeutic Plasma Exchange in Pediatric Intensive Care Unit: A Single-center Experience.

Authors:  Serkan Özsoylu; Adem Dursun; Binnaz Çelik
Journal:  Indian J Crit Care Med       Date:  2021-10

3.  Safety of Therapeutic Apheresis in Children and Adolescents.

Authors:  Christina Taylan; Anne Schaaf; Corina Dorn; Claus Peter Schmitt; Sebastian Loos; Nele Kanzelmeyer; Lars Pape; Dominik Müller; Lutz T Weber; Julia Thumfart
Journal:  Front Pediatr       Date:  2022-04-12       Impact factor: 3.418

4.  Use of Therapeutic Plasma Exchange in the Pediatric Intensive Care Unit.

Authors:  Ahmet Gökcan Öztürk; Zeynep Erva Küçük; Serhan Özcan; Merve Havan; Emrah Gün; Edin Botan; Tanıl Kendirli
Journal:  Turk Arch Pediatr       Date:  2022-03

5.  Therapeutic plasma exchange in the intensive care unit and with the critically ill, a focus on clinical nursing considerations.

Authors:  Ian Baldwin; Sarah Todd
Journal:  J Clin Apher       Date:  2022-04-06       Impact factor: 2.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.